Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - tamsulosinum - retardtablette - tamsulosini hydrochloridum 400 µg corresp. tamsulosinum 367 µg, macrogolum 8000, magnesii stearas, macrogolum 7'000'000 cum e 321 et silica colloidalis hydrica, Überzug: hypromellosum, macrogolum 8000, e 172 (flavum), pro compresso obducto. - iperplasia prostatica benigna - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, polyethyleni oxidum cum e 321, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - iperplasia prostatica benigna - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - tamsulosinum - retardtabletten - tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.376 mg, hypromellosum, cellulosum microcristallinum, carbomerum, silica colloidalis anhydrica, magnesii stearas, e 172 (rubrum), pro compresso. - iperplasia prostatica benigna - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - dutasteridum, tamsulosinum - capsule - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, propylenglycoli monooctanoas corresp. propylenglycolum 112.65 mg, e 321, gelatina, glycerolum, e 171, acidi methacrylici et ethylis acrylatis polymerisatum 1:1 cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.09 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: gelatina, e 171, e 172 (nigrum), e 172 (rubrum), e 172 (flavum), drucktinte: propylenglycolum, lacca, e 172 (nigrum), ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - dutasteridum, tamsulosinum - capsule rigide - dutasteridum 0.5 mg, tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, dutasterid-weichkapsel innerhalb der hartkapsel: propylenglycoli dicaprylocapras corresp. propylenglycolum 112.65 mg, e 321, gelatina, glycerolum, e 171, triglycerida media, lecithinum ex soja q.s., tamsulosin-pellets in hartkapsel: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum polysorbatum 80 et natrii laurilsulfas corresp. natrium 0.026 mg, cellulosum microcristallinum, dibutylis sebacas, silica colloidalis hydrica, calcii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 171, e 172 (flavum), gelatina, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula. - iperplasia prostatica benigna - synthetika